FI933037A0 - Tiazolylvinylfenylderivat - Google Patents
TiazolylvinylfenylderivatInfo
- Publication number
- FI933037A0 FI933037A0 FI933037A FI933037A FI933037A0 FI 933037 A0 FI933037 A0 FI 933037A0 FI 933037 A FI933037 A FI 933037A FI 933037 A FI933037 A FI 933037A FI 933037 A0 FI933037 A0 FI 933037A0
- Authority
- FI
- Finland
- Prior art keywords
- tiazolylvinylfenylderivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/907,987 US5273986A (en) | 1992-07-02 | 1992-07-02 | Cycloalkylthiazoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI933037A0 true FI933037A0 (fi) | 1993-07-01 |
| FI933037A FI933037A (fi) | 1994-01-03 |
Family
ID=25424972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI933037A FI933037A (fi) | 1992-07-02 | 1993-07-01 | Tiazolylvinylfenylderivat |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5273986A (fi) |
| EP (1) | EP0577003A1 (fi) |
| JP (1) | JPH0680654A (fi) |
| KR (1) | KR940005602A (fi) |
| CN (1) | CN1087086A (fi) |
| AU (1) | AU667107B2 (fi) |
| BR (1) | BR9302737A (fi) |
| CA (1) | CA2099295A1 (fi) |
| CZ (1) | CZ133493A3 (fi) |
| FI (1) | FI933037A (fi) |
| HU (1) | HUT72747A (fi) |
| IL (1) | IL106141A0 (fi) |
| MX (1) | MX9303958A (fi) |
| NO (1) | NO932399L (fi) |
| NZ (1) | NZ247988A (fi) |
| PL (1) | PL299544A1 (fi) |
| UY (1) | UY23609A1 (fi) |
| ZA (1) | ZA934603B (fi) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830854A (en) * | 1992-12-14 | 1998-11-03 | Merck Sharp & Dohme, Limited | Method of treating cystic fibrosis using a tachykinin receptor antagonist |
| WO1996008479A1 (en) * | 1994-09-13 | 1996-03-21 | F. Hoffmann-La Roche Ag | A process of making (e)-4-[3-[2-(4-cycloalkyl-2-thiazolyl)ethenyl]phenyl]amino-2,2-alkyldiyl-4-oxobutanoic acid |
| HUT77609A (hu) * | 1994-10-14 | 1998-06-29 | Yamanouchi Pharmaceutical Co. Ltd. | Azolszármazékok, az ezeket tartalmazó gyógyszerkészítmények és a vegyületek intermedierjei |
| JPH11506425A (ja) * | 1995-04-21 | 1999-06-08 | 第一製薬株式会社 | エチニルチアゾール誘導体 |
| SE9804212D0 (sv) * | 1998-12-04 | 1998-12-04 | Astra Pharma Prod | Compounds |
| US7056917B2 (en) * | 2001-04-26 | 2006-06-06 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
| EP1389463A4 (en) * | 2001-04-26 | 2008-09-17 | Daiichi Seiyaku Co | MEDICAMENT FOR INHIBITING A DRUG REMOVAL PUMP |
| SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
| SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| KR20070007103A (ko) * | 2004-02-18 | 2007-01-12 | 아스트라제네카 아베 | 벤즈아미드 유도체 및 이의 글루코키나아제 활성화제로서의용도 |
| EP1718625A1 (en) * | 2004-02-18 | 2006-11-08 | AstraZeneca AB | Compounds |
| TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
| GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
| WO2006040527A1 (en) | 2004-10-16 | 2006-04-20 | Astrazeneca Ab | Process for making phenoxy benzamide compounds |
| EP1891069A1 (en) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
| JP2009500442A (ja) * | 2005-07-09 | 2009-01-08 | アストラゼネカ アクチボラグ | ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物 |
| US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| US7642259B2 (en) * | 2005-07-09 | 2010-01-05 | Astrazeneca Ab | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
| TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
| TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
| SA07280576B1 (ar) * | 2006-10-26 | 2011-06-22 | استرازينيكا ايه بي | مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز |
| BRPI0721143A2 (pt) * | 2006-12-21 | 2014-03-11 | Astrazeneca Ab | Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase |
| KR20110052676A (ko) | 2008-08-04 | 2011-05-18 | 아스트라제네카 아베 | 피라졸로[3,4]피리미딘-4-일 유도체 및 당뇨병 및 비만을 치료하기 위한 이의 용도 |
| GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
| GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
| AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
| AR076221A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
| DK2482815T3 (en) | 2009-10-02 | 2018-06-06 | Avexxin As | ANTI-INFLAMMATORY 2-OXOTHIAZOLES AND 2-OXOOXAZOLES |
| KR102268357B1 (ko) | 2013-01-29 | 2021-06-23 | 아벡신 에이에스 | 항염증성 및 항종양성 2-옥소티아졸 및 2-옥소티오펜 화합물 |
| GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
| GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| WO2019148005A1 (en) * | 2018-01-26 | 2019-08-01 | Nurix Therapeutics, Inc. | Inhibitors of cbl-b and methods of use thereof |
| BR112021019722A2 (pt) | 2019-04-09 | 2021-12-14 | Nurix Therapeutics Inc | Compostos de piperidina 3-substituídos para inibição de cbl-b, e uso de inibidor de cbl-b em combinação com vacina contra câncer e/ou vírus oncolítico |
| EP3969447A1 (en) | 2019-05-17 | 2022-03-23 | Nurix Therapeutics, Inc. | Cyano cyclobutyl compounds for cbl-b inhibition and uses thereof |
| JP2022538174A (ja) | 2019-06-26 | 2022-08-31 | ニューリックス セラピューティクス，インコーポレイテッド | Ｃｂｌ－ｂ阻害のための置換ベンジル－トリアゾール化合物、及びそのさらなる使用 |
| CA3152293A1 (en) | 2019-09-24 | 2021-04-01 | Arthur T. Sands | Cbl inhibitors and compositions for use in adoptive cell therapy |
| CA3214729A1 (en) | 2021-04-08 | 2022-10-13 | Marilena GALLOTTA | Combination therapies with cbl-b inhibitor compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62142168A (ja) * | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| JPS63258854A (ja) * | 1987-04-16 | 1988-10-26 | Mitsubishi Kasei Corp | カルボキシスチレン誘導体およびそれを有効成分とする薬剤 |
| DE3723913A1 (de) * | 1987-07-18 | 1989-02-23 | Shell Agrar Gmbh & Co Kg | Neue phosphoniumsalze, ihre herstellung und verwendung |
| EP0318085A3 (en) * | 1987-11-25 | 1990-03-14 | Merck Frosst Canada Inc. | Heterazole dialkanoic acids |
| US5001140A (en) * | 1989-04-17 | 1991-03-19 | Hoffmann-La Roche Inc. | Cycloalkylthiazoles |
| EP0355353B1 (en) * | 1988-07-15 | 1994-03-16 | F. Hoffmann-La Roche Ag | Cycloalkylthiazole derivatives |
| JPH02169583A (ja) * | 1988-12-22 | 1990-06-29 | Mitsubishi Kasei Corp | ビニルチアゾール誘導体およびそれを有効成分とする薬剤 |
| AU654140B2 (en) * | 1990-07-31 | 1994-10-27 | Lilly Industries Limited | N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them |
-
1992
- 1992-07-02 US US07/907,987 patent/US5273986A/en not_active Expired - Fee Related
-
1993
- 1993-06-24 EP EP93110073A patent/EP0577003A1/en not_active Withdrawn
- 1993-06-25 ZA ZA934603A patent/ZA934603B/xx unknown
- 1993-06-25 NZ NZ247988A patent/NZ247988A/en unknown
- 1993-06-25 IL IL106141A patent/IL106141A0/xx unknown
- 1993-06-28 AU AU41562/93A patent/AU667107B2/en not_active Expired - Fee Related
- 1993-06-28 CA CA002099295A patent/CA2099295A1/en not_active Abandoned
- 1993-06-28 HU HU9301881A patent/HUT72747A/hu unknown
- 1993-06-29 JP JP5185437A patent/JPH0680654A/ja active Pending
- 1993-06-30 MX MX9303958A patent/MX9303958A/es unknown
- 1993-06-30 UY UY23609A patent/UY23609A1/es unknown
- 1993-07-01 PL PL29954493A patent/PL299544A1/xx unknown
- 1993-07-01 FI FI933037A patent/FI933037A/fi not_active Application Discontinuation
- 1993-07-01 BR BR9302737A patent/BR9302737A/pt not_active Application Discontinuation
- 1993-07-01 CN CN93109528A patent/CN1087086A/zh active Pending
- 1993-07-01 NO NO932399A patent/NO932399L/no unknown
- 1993-07-01 CZ CZ931334A patent/CZ133493A3/cs unknown
- 1993-07-01 KR KR1019930012260A patent/KR940005602A/ko not_active Application Discontinuation
- 1993-09-02 US US08/116,386 patent/US5399702A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5273986A (en) | 1993-12-28 |
| AU667107B2 (en) | 1996-03-07 |
| US5399702A (en) | 1995-03-21 |
| MX9303958A (es) | 1994-04-29 |
| CA2099295A1 (en) | 1994-01-03 |
| KR940005602A (ko) | 1994-03-21 |
| AU4156293A (en) | 1994-01-06 |
| BR9302737A (pt) | 1994-02-08 |
| HU9301881D0 (en) | 1993-09-28 |
| NO932399D0 (no) | 1993-07-01 |
| IL106141A0 (en) | 1993-10-20 |
| CN1087086A (zh) | 1994-05-25 |
| ZA934603B (en) | 1994-01-05 |
| NZ247988A (en) | 1995-11-27 |
| EP0577003A1 (en) | 1994-01-05 |
| FI933037A (fi) | 1994-01-03 |
| HUT72747A (en) | 1996-05-28 |
| UY23609A1 (es) | 1993-12-21 |
| CZ133493A3 (en) | 1994-01-19 |
| PL299544A1 (en) | 1994-02-21 |
| JPH0680654A (ja) | 1994-03-22 |
| NO932399L (no) | 1994-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO932399D0 (no) | Tiazolylvinylfenylderivater | |
| DE59303358D1 (de) | Quaterrylentetracarbonsäureimide | |
| DE59306810D1 (de) | Gutbettwalzenmühle | |
| DE59302851D1 (de) | Sportschuh | |
| FI932864L (fi) | Elektriskt uppvaermbar kalendervals | |
| FI931837L (fi) | Rakelbalk foer en faerganordning | |
| DE59301902D1 (de) | Kassenlade | |
| DE59305364D1 (de) | Rotornut | |
| NO930921D0 (no) | Eksplosiv-arrangement | |
| DE69304512D1 (de) | Laseroszillator | |
| DE69306208D1 (de) | Ablenkjoch | |
| FI934778L (fi) | 4-heterocyklylsubstituerade dihyropyridiner | |
| DE59304139D1 (de) | Polyanile | |
| ATA227792A (de) | Sportschuh | |
| DE59309200D1 (de) | Bisphosphinoalkane | |
| FIU920628U0 (fi) | Steganordning | |
| DE59301762D1 (de) | Chlorethylsulfonylbenzaldehyde | |
| BR7200879U (pt) | Cocho saleiro biazi | |
| ATA27393A (de) | Alpinski | |
| BR9200231A (pt) | Agrupador | |
| BR7200318U (pt) | Cabide sanfonado | |
| BR7200240U (pt) | Vari-watt | |
| BR9200295A (pt) | Aurissima | |
| BR7200229U (pt) | Doca-dupla | |
| BR9200296A (pt) | Varre-lava |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |